GIMS2
Timeline
33 events since 2004Board
Filings
Financial
Establishments
Address
200420062008201020122014201620182020202220242026
2025
Annual accounts 2024 filed PDFabbreviated format · 124 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0866864254
2024
Annual accounts 2023 filed PDFabbreviated format · 116 days late
2023
Equity above €500,000 equity €502,654 ▲2.5% After 7 profitable years in a row, equity reaches €502,654.
Annual accounts 2022 filed PDFabbreviated format · 31 days late
2022
Annual accounts 2021 filed PDFabbreviated format · 19 days late
2021
Annual accounts 2020 filed PDFabbreviated format · 23 days late
2020
Annual accounts 2019 filed PDFabbreviated format · 28 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 23 days late
2018
Liquidity more than 17 times current ratio 2.02 The current ratio rises from 0.11 to 2.02.
Equity above €200,000 equity €334,150 ▲158% After 2 profitable years in a row, equity reaches €334,150.
Annual accounts 2017 filed PDFabbreviated format · 142 days late
Company renamed from De Boer Biotech to GIMS2Resignation: (statutory manager) · Appointments: (manager) and (manager) · Permanent representative: 6 points ▸
- Purpose change, “De aan- verkoop,de import en export,de groot- en kleinhandel van alcoholhoudende dranken,in het bijzonder wijnen; Zin; Het organiseren van wijnproeverijen en…” (deed in Dutch)
- Name change, GIMS2
- Director resignation, (statutory manager)
- Director appointment, (manager)
- Director appointment, (manager)
- Permanent representative,
- The deed holds 1 more point.
2017
Back to profit net €288,520 The net result is €288,520, after one loss-making year.
Annual accounts 2016 filed PDFabbreviated format · 53 days late
Registered office moved within Oud-HeverleeNew registered office: Maurits Noestraat 31 te 3050 Oud-Heverlee · Previous registered office: Maurits Noestraat 33, 3050 Oud-Heverlee · General meeting of 25-05-20172 points ▸
- General meeting, 25-05-2017
- Registered-office move, Maurits Noestraat 31 te 3050 Oud-Heverlee
2016
Annual accounts 2015 filed PDFabbreviated format · 23 days late
2015
Liquidity more than 15 times current ratio 2.62 The current ratio rises from 0.17 to 2.62.
Annual accounts 2014 filed PDFabbreviated format · 20 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 115 days late
2013
Back to profit net €39,908 The net result is €39,908, after 5 loss-making years.
Annual accounts 2012 filed PDFabbreviated format · 30 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 13 days late
2011
Weakest financial year net -€211,424 The net result drops to -€211,424, the lowest from 2006 to 2024. It recovers the following year.
Annual accounts 2010 filed PDFabbreviated format · 9 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 30 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 24 days before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · 30 days before the deadline
2007
Equity above €150,000 equity €168,478 ▲13.1% With a profit in every financial year since 2006, equity grows to €168,478.
Annual accounts 2006 filed PDFabbreviated format · 25 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2004
Incorporation PDFpublished on 30-08-2004
First establishment De Boer Biotech, Maurits Noëstraat 31, Oud-Heverlee
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank